Preventive Medicine Doctors in Vancouver, WA Accepting Medicare

4 Preventive Medicine doctors found. Showing 1 - 4

Peter K Black, MD Preventive Medicine - Undersea and Hyperbaric Medicine Medicare: Accepting Medicare Assignments Practice Location: 8716 E Mill Plain Blvd, Vancouver, WA 98664 Phone: 360-514-4325    Fax: 360-514-4336

Craig F. Thompson, MD Preventive Medicine - Occupational Medicine Medicare: Not Enrolled in Medicare Practice Location: 2621 Ne 134th St, Suite 310, Vancouver, WA 98686 Phone: 360-891-4900    Fax: 360-546-3510

Juliet Tran, M.D, M.P.H. Preventive Medicine - Occupational Medicine Medicare: Medicare Enrolled Practice Location: 17700 Se Mill Plain Blvd, Vancouver, WA 98683 Phone: 504-988-2838

Erik D Geissal, MD Preventive Medicine - Clinical Informatics Medicare: Accepting Medicare Assignments Practice Location: 7809 Ne Vancouver Plaza Dr Ste 110, Vancouver, WA 98662 Phone: 360-882-2778    Fax: 360-604-1728

News Archive

MabCure, CUNY CAT partner to evaluate monoclonal antibodies against ovarian cancer cells

MabCure Inc., leading developer of antibody based technology for the diagnosis and treatment of Ovarian, Prostate, Colorectal and other cancers today announced it has entered into an agreement with the City University of New York Center for Advanced Technology (CUNY CAT) to evaluate its monoclonal antibodies against ovarian cancer cells as diagnostic reagents.

End-of-life terminologies and prior experience matter to surrogate decision makers

Many people do not prepare advanced directives for their end-of-life medical care, so family members must make treatment decisions on their behalf.

FDA grants CSI marketing clearance for Stealth 360° Orbital PAD System

Cardiovascular Systems, Inc. has received 510(k) marketing clearance from the U.S. Food and Drug Administration (FDA), and has begun a limited market release for the Stealth 360°™ Orbital PAD System. The Stealth 360° propels CSI into the forefront of treating peripheral arterial disease (PAD) with a simpler design that gives physicians complete control of device operation.

USPTO issues patent for Avila's targeted covalent drugs portfolio

Avila Therapeutics, Inc., a biotechnology company developing targeted covalent drugs that treat diseases through protein silencing, announced today that the United States Patent and Trademark Office has issued Patent No. 7,982,036, "4,6-Disubstituted Pyrimidines Useful as Kinase Inhibitors."

Read more Medical News

› Verified 5 days ago